Inventor · disambiguated record
Masayuki Tsuchiya
Also filed as: TSUCHIYA MASAYUKI
46 granted patents·24 pending applications·1,876 citations·filing 1992–2022
98Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD45TSUCHIYA MASAYUKI5ABURATANI HIROYUKI2KIKUCHI YASUFUMI2OZAKI SHUJI2
Top patents by PatentIndex Score
70 records- 0198US7479543B2Reshaped human antibody to human interleukin-6 receptorCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Granted Jan 20, 2009·239 cites·1 claims
- 0298US5795965AReshaped human to human interleukin-6 receptorCHUGAI PHARMACEUTICAL CO LTD·Filed 1992·Granted Aug 18, 1998·368 cites·6 claims
- 0397US5817790AReshaped human antibody to human interleukin-6 receptorCHUGAI PHARMACEUTICAL CO LTD·Filed 1995·Granted Oct 6, 1998·233 cites·6 claims
- 0496US7052873B2Natural human antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 1998·Granted May 30, 2006·151 cites·8 claims
- 0595US5856135AReshaped human antibody to human interleukin-6CHUGAI PHARMACEUTICAL CO LTD·Filed 1994·Granted Jan 5, 1999·155 cites·8 claims
- 0694US6121423AReshaped human antibody to human interleukin-6CHUGAI PHARMACEUTICAL CO LTD·Filed 1998·Granted Sep 19, 2000·121 cites·3 claims
- 0792US8586039B2Degraded TPO agonist antibodyTSUCHIYA MASAYUKI·Filed 2011·Granted Nov 19, 2013·20 cites·27 claims
- 0892US8008073B2Anti-Mpl antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2010·Granted Aug 30, 2011·12 cites·33 claims
- 0991US7744880B2Cell growth inhibitors containing anti-glypican 3 antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2007·Granted Jun 29, 2010·13 cites·4 claims
- 1091US6245894B1Reshaped human antibody to human interleukin-8CHUGAI PHARMACEUTICAL CO LTD·Filed 1999·Granted Jun 12, 2001·65 cites·7 claims
- 1191US5994524APolynucleotides which encode reshaped IL-8-specific antibodies and methods to produce the sameCHUGAI PHARMACEUTICAL CO LTD·Filed 1995·Granted Nov 30, 1999·72 cites·30 claims
- 1289US8263077B2Cell growth inhibitors containing anti-glypican 3 antibodyABURATANI HIROYUKI·Filed 2010·Granted Sep 11, 2012·11 cites·5 claims
- 1387US8257703B2Anti-ganglioside antibodies and compositionsIRIE REIKO·Filed 2010·Granted Sep 4, 2012·11 cites·20 claims
- 1487US8101719B2Humanized anti-CD47 antibodyKIKUCHI YASUFUMI·Filed 2004·Granted Jan 24, 2012·27 cites·6 claims
- 1587US7696325B2Polypeptide inducing apoptosisCHUGAI PHARMACEUTICAL CO LTD·Filed 2001·Granted Apr 13, 2010·22 cites·19 claims
- 1687US6024956AMethod to treat inflammation with humanized anti-IL-8-antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 1997·Granted Feb 15, 2000·59 cites·3 claims
- 1786US7993642B2Anti-MPL antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Granted Aug 9, 2011·11 cites·27 claims
- 1886US6989244B1Method for screening compounds inhibiting signal transduction through inflammatory cytokinesCHUGAI PHARMACEUTICAL CO LTD·Filed 1999·Granted Jan 24, 2006·71 cites·20 claims
- 1983US8034903B2Degraded TPO agonist antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2001·Granted Oct 11, 2011·8 cites·11 claims
- 2083US6608188B1CRT-1 gene having reverse transcriptase motifCHUGAI PHARMACEUTICAL CO LTD·Filed 1999·Granted Aug 19, 2003·40 cites·8 claims
- 2182US8759025B2Humanized anti-CD47 antibodyKIKUCHI YASUFUMI·Filed 2011·Granted Jun 24, 2014·4 cites·10 claims
- 2281US6551840B2Method of screening TGF-β-inhibiting substancesCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted Apr 22, 2003·16 cites·8 claims
- 2379US6908750B2Gene encoding HM1.24 antigen protein and promoter thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2003·Granted Jun 21, 2005·4 cites·11 claims
- 2476US8008076B2Method of producing a nucleic acid encoding an antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2005·Granted Aug 30, 2011·3 cites·17 claims
- 2576US7709615B2Polynucleotides encoding anti-ganglioside antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Granted May 4, 2010·11 cites·25 claims
- 2676US7691588B2Ligand having agonistic activity to mutated receptorCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Granted Apr 6, 2010·14 cites·26 claims
- 2775US6699974B2Reshaped human anti-HM 1.24 antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 1997·Granted Mar 2, 2004·32 cites·9 claims
- 2875US6214973B1Reshaped human antibody to human medulloblastoma cellsCHUGAI PHARMACEUTICAL CO LTD·Filed 1994·Granted Apr 10, 2001·26 cites·18 claims
- 2974US8158385B2Cell death-inducing agentOZAKI SHUJI·Filed 2003·Granted Apr 17, 2012·12 cites·9 claims
- 3067US8343761B2Methods of generating and using antibody-producing cellsCHUGAI PHARMACEUTICAL CO LTD·Filed 2011·Granted Jan 1, 2013·1 cites·35 claims
- 3167US7863042B2Fucose transporterCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Granted Jan 4, 2011·1 cites·11 claims
- 3266US7563599B2Reshaped human antibody to human medulloblastoma cellsCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Granted Jul 21, 2009·0 cites·2 claims
- 3363US7892543B2Reshaped human anti-HM 1.24 antibodyChugai Seiyako Kabushiki Kaisha·Filed 2002·Granted Feb 22, 2011·3 cites·46 claims
- 3463US2009311718A1Degraded agonist antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2009·Application pending·0 cites
- 3561US7338797B2Compositions for isolating a cDNA encoding a membrane-bound proteinCHUGAI PHARMACEUTICAL CO LTD·Filed 2003·Granted Mar 4, 2008·0 cites·20 claims
- 3660US6949373B2Proteins having a reverse transcriptase motifCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted Sep 27, 2005·0 cites·6 claims
- 3759US6068840ARecombinant CDR-grafted and chimeric anti-IL-8 antibodies containing CDRs or the variable region from the mouse monoclonal antibody, WS-4CHUGAI PHARMACEUTICAL CO LTD·Filed 1997·Granted May 30, 2000·11 cites·10 claims
- 3858US2005019780A1Compositions for isolating a cDNA encoding a membrane-bound proteinCHUGAI SEIYAKU KUBUSHIKI KAISH·Filed 2003·Application pending·0 cites
- 3957US6610485B1Methods for isolating a cDNA encoding a membrane-bound proteinCHUGAI PHARMACEUTICAL CO LTD·Filed 1999·Granted Aug 26, 2003·8 cites·13 claims
- 4057US2005272092A1Novel gene having reverse transcriptas motifCHUGAI PHARMACEUTICAL CO LTD·Filed 2005·Application pending·0 cites
- 4155US8946386B2Proteins expressed in NK cellsMATSUSHIMA KOUJI·Filed 2004·Granted Feb 3, 2015·0 cites·19 claims
- 4255US8105799B2Methods of screening compounds inhibiting signal transduction through inflammatory cytokinesTSUCHIYA MASAYUKI·Filed 2008·Granted Jan 31, 2012·0 cites·16 claims
- 4355US2002082396A1Reshaped human antibody to human interleukin-8Filed 2000·Application pending·0 cites
- 4455US2008009038A1Methods for Enhancing Antibody ActivityCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Application pending·0 cites
- 4554US2006040316A1Method for screening compounds inhibiting signal transduction through inflammatory cytokinesCHUGAI PHARMACEUTICAL CO LTD·Filed 2005·Application pending·0 cites
- 4654US2013295096A1Degraded agonist antibodyFUKUSHIMA NAOSHI·Filed 2013·Application pending·0 cites
- 4754US2004258684A1Agonist antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Application pending·0 cites
- 4854US2003023045A1Reshaped human antibody to human medulloblastoma cellsFiled 2000·Application pending·0 cites
- 4953US2007280951A1Cell Death Inducing AgentsKIMURA NAOKI·Filed 2004·Application pending·0 cites
- 5052US2006235207A1Antibodies against lesion tissuePHARMALOGICALS RES PTE LTD·Filed 2003·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Masayuki Tsuchiya files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →